» Articles » PMID: 9241704

Risk Factors for Venous Thrombosis: Prevalence, Risk, and Interaction

Overview
Journal Semin Hematol
Specialty Hematology
Date 1997 Jul 1
PMID 9241704
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Annually, 1 in 1,000 individuals is affected by venous thrombosis. Risk factors that are known to increase the risk of thrombosis may be either genetic or acquired, or have a combined origin. Many of these risk factors are very frequent, among which several have been recently identified, such as resistance to activated protein C by factor V Leiden, hyperhomocysteinemia, high levels of factors VIII, as well as the classical acquired risk factors, such as surgery and malignancies. When the prevalence of risk factors is high, it becomes likely that in some individuals two or more risk factors will be present simultaneously. The question "What happens to the risk in these circumstances?" is one involving interaction, also known as effect modification or synergy. In this article we review the prevalence and risk estimates for the various genetic and acquired risk factors for venous thrombosis, discuss the concept of interaction, and give an overview of the evidence for interaction of these risk factors.

Citing Articles

Incidence and factors associated with deep vein thrombosis among hospitalized adult patients at Hawassa university comprehensive specialized hospital Hawassa city, Sidama, Ethiopia: retrospective cohort study.

Alemu T, Adule A, Sorato M, Borsamo A J Thromb Thrombolysis. 2023; 57(1):164-174.

PMID: 37704907 DOI: 10.1007/s11239-023-02889-5.


Reduced Activity of Protein S in Plasma: A Risk Factor for Venous Thromboembolism in the Japanese Population.

Jin X, Kinoshita S, Kuma H, Tsuda T, Yoshida T, Kang D Clin Appl Thromb Hemost. 2021; 27:10760296211033908.

PMID: 34286618 PMC: 8299880. DOI: 10.1177/10760296211033908.


Sarcoidosis as a risk factor for venous thromboembolism.

Goljan Geremek A, Tomkowski W, Geremek M, Puscinska E, Malek G, Nowinski A Sarcoidosis Vasc Diffuse Lung Dis. 2020; 34(2):170-178.

PMID: 32476839 PMC: 7170146. DOI: 10.36141/svdld.v34i2.4911.


Prophylaxis and Therapy of Venous Thrombotic Events (VTE) in Pregnancy and the Postpartum Period.

Sucker C Geburtshilfe Frauenheilkd. 2020; 80(1):48-59.

PMID: 31949319 PMC: 6957355. DOI: 10.1055/a-1030-4546.


Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer: A case-control study.

Lin H, Liao K, Chang C, Lin C, Lai S, Hsu C Medicine (Baltimore). 2018; 97(51):e12842.

PMID: 30572423 PMC: 6320050. DOI: 10.1097/MD.0000000000012842.